We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Treatments for Inflammatory Diseases Sought by Singapore's CREATE Program

By LabMedica International staff writers
Posted on 06 Jul 2010
Internationally renowned top-ranked investigators in the biological sciences and other areas will be cooperating in Singapore's National Research Foundation's CREATE research (Campus for Research Excellence and Technological Enterprise) program.

CREATE has been designed to be a talent magnet and innovation hub. The research centers in CREATE will host professors, research investigators, doctoral, and postdoctoral researchers who will form research groups to pursue research programs in areas that are aligned both to Singapore's strategic interest and those of the respective institutions. CREATE entities will have intensive collaboration with Singapore-based universities, polytechnics, laboratories, and research institutes, in cutting-edge research projects and in the attraction of global talent.

A recently announced participant in the CREATE program is the Hebrew University of Jerusalem (Israel). The Hebrew University's research project will focus on cellular and molecular mechanisms of inflammation. The objective of the project is to accelerate the development of diagnostic/prognostic indicators and novel therapeutics for common inflammatory diseases in Asia and elsewhere.

"This collaborative research program will leverage on the existing strengths
of both Hebrew University and National University of Singapore. We see great strategic value in this research, given the increasing prevalence of inflammatory diseases throughout the region. We expect our work to lead to scientific breakthroughs in understanding and developing therapies for inflammatory diseases,” said Dr. Ehud Razin professor of cancer research at the Hebrew University of Jerusalem.

Dr. Tan Chorh Chuan, president of the National University of Singapore, said, "Discovery and evaluation of new treatments for inflammatory diseases continue to be of critical importance. We are pleased to partner with the Hebrew University of Jerusalem under the CREATE program. With strong commitment from both sides, we are confident that this collaboration will have a major impact by addressing important research and medical needs, both in the region and the world.”

Related Links:
Singapore's National Research Foundation's
Hebrew University of Jerusalem
National University of Singapore



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chlamydia Test Kit
CHLAMYTOP
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries